Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 119, Issue 9, Pages 1067-1074
Publisher
Springer Nature America, Inc
Online
2018-10-19
DOI
10.1038/s41416-018-0310-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial
- (2018) B.G. Wortman et al. GYNECOLOGIC ONCOLOGY
- A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study
- (2017) M. Randall et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
- (2016) Louis JM van der Putten et al. BRITISH JOURNAL OF CANCER
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
- (2016) Inge C Van Gool et al. MODERN PATHOLOGY
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
- (2015) Tjalling Bosse et al. EUROPEAN JOURNAL OF CANCER
- Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
- (2015) Stephanie M. de Boer et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
- (2014) T. Bosse et al. EUROPEAN JOURNAL OF CANCER
- Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
- (2014) David N. Church et al. JNCI-Journal of the National Cancer Institute
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
- (2013) Alain G. Zeimet et al. JNCI-Journal of the National Cancer Institute
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma
- (2011) Carien L. Creutzberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma—A Prospective Randomized Study
- (2011) Bengt Sorbe et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Role for Adjuvant Radiation in Clinically Early Carcinoma of the Endometrium?
- (2010) Gillian Monica Thomas INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial
- (2009) Remi A. Nout et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphadenectomy in endometrial cancer – Authors' reply
- (2009) Henry Kitchener et al. LANCET
- Mandatory Second Opinion in Surgical Pathology Referral Material: Clinical Consequences of Major Disagreements
- (2008) Elizabeth Manion et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
- (2008) P. B. Panici et al. JNCI-Journal of the National Cancer Institute
- Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
- (2007) Nobuyuki Susumu et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation